Latest market price
23.19
+0.42+1.84%
TA
Loading chart...
Snapshot
| Index | — | P/E | 6.18 | EPS (ttm) | 3.75 | Insider Own | 15.95% | Shs Outstand | 201.65M | Perf Week | 8.47% |
| Market Cap | 4.68B | Forward P/E | 8.39 | EPS next Y | 2.77 | Insider Trans | 0.00% | Shs Float | 200.76M | Perf Month | 44.40% |
| Enterprise Value | 8.63B | PEG | 1.47 | EPS next Q | 0.11 | Short Float | 8.73% | Perf Quarter | 10.11% | ||
| Income | 781.00M | P/S | 0.65 | EPS this Y | -9.59% | Short Ratio | 2.71 | Perf Half Y | 24.95% | ||
| Sales | 7.21B | P/B | — | EPS next Y | 2.64% | ROA | 15.15% | Short Interest | 17.52M | Perf YTD | 15.49% |
| Book/sh | -5.23 | P/C | 5.89 | EPS next 5Y | 4.19% | ROE | — | 52W High | 25.21 -8.01% | Perf Year | -3.09% |
| Cash/sh | 3.94 | P/FCF | 4.54 | EPS past 3/5Y | -3.63% 0.46% | ROIC | 24.92% | 52W Low | 14.28 62.39% | Perf 3Y | -19.17% |
| Dividend Est. | 0.80 (3.45%) | EV/EBITDA | 5.85 | Sales past 3/5Y | -1.20% 2.53% | Gross Margin | 44.12% | Volatility | 3.22% 4.21% | Perf 5Y | -67.31% |
| Dividend TTM | 0.80 (3.45%) | EV/Sales | 1.20 | EPS Y/Y TTM | 11.61% | Oper. Margin | 16.74% | ATR (14) | 0.87 | Perf 10Y | -60.42% |
| Dividend Ex-Date | Aug 21, 2026 | Quick Ratio | 0.68 | Sales Y/Y TTM | -2.17% | Profit Margin | 10.83% | RSI (14) | 73.00 | Recom | 2.59 |
| Dividend Gr. 3/5Y | 0.00% 26.96% | Current Ratio | 1.20 | EPS Q/Q | 67.57% | SMA20 | 15.14% | Beta | 1.31 | Target Price | 21.17 |
| Payout | 20.74% | Debt/Eq | — | Sales Q/Q | -2.26% | SMA50 | 24.39% | Rel Volume | 1.06 | Prev Close | 22.77 |
| Employees | 60,735 | LT Debt/Eq | — | Earnings | Nov 19 | SMA200 | 17.12% | Avg Volume | 6.76M | Price | 23.19 |
| IPO Date | Apr 01, 1982 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 155.29% 1.11% | Net Debt/EBITDA | 2.68 | Volume | 7,157,170 | Change | 1.84% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-08-26 | Initiated | BMO Capital | Market Perform | $50 → $20 |
| Sep-08-26 | Reiterated | China Renaissance Securities (US) Inc. | $20 | |
| Aug-27-26 | Reiterated | Deutsche Bank | Buy | $23 → $22 |
| Aug-27-26 | Reiterated | Robert W. Baird | $25 → $23 | |
| Aug-27-26 | Reiterated | Wells Fargo | Overweight | $26 → $24 |
| Aug-27-26 | Reiterated | Barclays | Equal Weight | $23 → $22 |
| Aug-27-26 | Reiterated | Morgan Stanley | Equal Weight | $22 → $20 |
| Aug-18-26 | Upgrade | Citigroup | Neutral → Buy | |
| Jul-28-26 | Reiterated | Jefferies | Hold | $24 → $23 |
| Jul-08-26 | Downgrade | Goldman Sachs | Neutral → Sell | $23 → $19 |
Latest News· Times ET
Nov-02-26
Oct-29-26
10:41AM
Oct-26-26
Oct-26-2610:29AM
Oct-23-26
Oct-23-2609:00AM
Oct-22-26
Oct-22-2610:45AM
Oct-15-26
Oct-15-2610:39AM
Oct-13-26
Oct-09-26
Oct-09-2611:16AM
Oct-08-26
Oct-08-2610:31AM
Oct-06-26
Sep-30-26
Sep-29-26
Company
Bath & Body Works, Inc. operates as a specialty retailer of personal care and home fragrance products. The company offers body and home fragrances, including 3-wick candles, home fragrance diffusers, fine fragrance mists, eau de parfum, body wash, hand soaps, body lotions, and body creams, as well as sanitizer and other products. It sells its products under the Bath & Body Works and other brand names through retail stores and e-commerce sites in the United States and Canada, as well as through international stores operated by partners under the franchise, license, and wholesale arrangements. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 1/31/2026 | FY 2024 2/1/2025 | FY 2023 2/3/2024 | FY 2022 1/28/2023 | FY 2021 1/29/2022 | FY 2020 1/30/2021 | FY 2019 1/31/2020 | FY 2018 1/31/2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 7,210 | 7,291 | 7,307 | 7,429 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 4,029 | 4,102 | 4,073 | 4,193 | — | — | — | — | — | |
| Gross Profit | 3,181 | 3,189 | 3,234 | 3,236 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 1,974 | 2,063 | 1,968 | 1,951 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Operating Income | 1,207 | 1,126 | 1,266 | 1,285 | — | — | — | — | — | |
| Interest Expense | 269 | 276 | 312 | 345 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 33 | 32 | 74 | 81 | — | — | — | — | — | |
| Net Income Before Taxes | 971 | 882 | 1,028 | 1,021 | — | — | — | — | — | |
| Income Taxes | 190 | 233 | 230 | 143 | — | — | — | — | — | |
| Consolidated Net Income | 781 | 649 | 798 | 878 | — | — | — | — | — | |
| Net Income From Continuing Operations | 781 | 649 | 798 | 878 | — | — | — | — | — | |
| Net Income | 781 | 649 | 798 | 878 | — | — | — | — | — | |
| EPS (Recurring) | 3.75 | 3.07 | 3.62 | 3.89 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 3.75 | 3.07 | 3.62 | 3.89 | — | — | — | — | — | |
| EPS (Diluted) | 3.75 | 3.07 | 3.61 | 3.83 | — | — | — | — | — | |
| EBITDA | 1,474 | 1,412 | 1,622 | 1,635 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 6.18 | 7.10 | 10.42 | 11.34 | — | — | — | — | — | |
| Price To Sales Ratio | 0.65 | 0.63 | 1.13 | 1.32 | — | — | — | — | — | |
| Gross Margin | 44.12 | 43.74 | 44.26 | 43.56 | — | — | — | — | — | |
| Operating Margin | 16.74 | 15.44 | 17.33 | 17.30 | — | — | — | — | — | |
| Net Margin | 10.83 | 8.90 | 10.92 | 11.82 | — | — | — | — | — | |
| Shares Outstanding | 202 | 212 | 220 | 226 | — | — | — | — | — | |
| Market Capitalization | 4,684 | 4,622 | 8,274 | 9,820 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Nash Sarah E | Director | Oct 16 '26 | Sale | 20.57 | 1 | 14 | 299,101 | Oct 20 |
| Nash Sarah E | Director | Nov 24 '25 | Buy | 15.58 | 10,000 | 155,800 | 285,522 | Nov 25 |
| Symancyk James Kevin | Director | Nov 24 '25 | Buy | 15.58 | 22,500 | 350,550 | 40,379 | Nov 25 |
| Hondal Francis | Director | Nov 21 '25 | Buy | 14.99 | 3,343 | 50,128 | 21,554 | Nov 24 |
| Voskuil Steven E | Director | Nov 21 '25 | Buy | 15.04 | 20,000 | 300,700 | 33,925 | Nov 24 |
| STEINOUR STEPHEN D | Director | Nov 21 '25 | Buy | 14.86 | 6,700 | 99,529 | 48,175 | Nov 24 |
| Brady Lucy | Director | Nov 21 '25 | Buy | 14.40 | 3,470 | 49,962 | 17,482 | Nov 24 |
| Nash Sarah E | Director | Mar 10 '25 | Option Exercise | 0.00 | 127,288 | 0 | 282,896 | Mar 12 |
| Boswell Gina | Chief Executive Officer | Oct 09 '24 | Buy | 29.64 | 6,000 | 177,852 | 242,987 | Oct 11 |
| Nash Sarah E | Director | Jun 18 '24 | Sale | 41.50 | 48,000 | 1,992,120 | 149,202 | Jun 20 |
| Mazurek Thomas E. | Chief Supply Chain Officer | Mar 27 '24 | Option Exercise | 43.75 | 2,285 | 99,975 | 50,277 | Mar 28 |
| Mazurek Thomas E. | Chief Supply Chain Officer | Mar 27 '24 | Sale | 48.89 | 4,285 | 209,515 | 45,992 | Mar 28 |
| Nash Sarah E | Director | Mar 10 '24 | Option Exercise | 0.00 | 123,544 | 0 | 222,502 | Mar 12 |
| Rosen Julie | President, Retail | Mar 01 '24 | Sale | 45.83 | 12,361 | 566,476 | 12,361 | Mar 05 |
| Nash Sarah E | Director | Aug 20 '23 | Option Exercise | 0.00 | 3,770 | 0 | 99,565 | Aug 22 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.